<DOC>
	<DOCNO>NCT01419158</DOCNO>
	<brief_summary>Alpha-1 antitrypsin deficiency ( AATD ) consider rare genetic cause chronic obstructive pulmonary disease ( COPD ) liver disease . Recent data suggest AATD rare originally think undetected AATD may account COPD patient . This study design evaluate frequency undetected AATD population report academic pulmonary function test facility meet criterion diagnosis COPD . All individual meet GOLD criterion COPD consent offer free test AATD . The result help identify percent COPD undetected AATD .</brief_summary>
	<brief_title>Prevalence Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>Male female adult least 18 year age able understand consent procedure protocol . All race ethnicity consider study . Postbronchodilator value pulmonary function test day enrollment FEV1 &lt; 80 % predict FEV1/FVC &lt; 70 % ( least GOLD stage II ) . Subjects test Alpha1 past know genotype phenotype may include study . Note : For inclusion criterion investigator use patient 's GOLD status , base percent predict ( FEV1 &lt; 80 % predict ) ; however , send absolute value FEV1 Data Coordinating Center ( DCC ) DCC calculate percent predict use standardized formula ( NHANES III ) . For site use predicted formula , result obtain DCC may differ use subject enrollment . ( For example , subject find FEV1 &lt; 80 % study site could FEV1 &gt; 80 % DCC recalculate ) . Enrollment base percent predict study site . If necessary , data small number outlier analyze separately . Subjects postbronchodilator spirometry perform . Subjects whose order physician specifically request patient consider enrollment . Patients test Alpha1 past know genotype phenotype .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Alpha-1 antitrypsin</keyword>
	<keyword>Alpha-1 antitrypsin deficiency</keyword>
	<keyword>Chronic obstructive pulmonary disease</keyword>
</DOC>